The role of the GLUT 4 transporter in regulating rat myoblast glucose transport processes  by Broydell, M et al.
 .Biochimica et Biophysica Acta 1371 1998 295–308
The role of the GLUT 4 transporter in regulating rat myoblast glucose
transport processes
M. Broydell, D.M. Mazzuca, P.A. Kudo, T.C.Y. Lo )
Department of Biochemistry, Uni˝ersity of Western Ontario, London, Ontario, Canada N6A 5C1
Received 4 February 1998; accepted 16 February 1998
Abstract
wPrevious studies revealed an inverse relationship between GLUT 1 and GLUT 4 expression in rat myoblasts L. Xia, Z.
 . xLu, T.C.Y. Lo, J. Biol. Chem., 268 1993 23258–23266 . It was not clear whether these were coincidental or causal
occurrences. To examine the regulatory roles of the GLUT 4 isoform, rat L6 myoblasts were transfected with full length
 .GLUT 4 cDNAs 2.5 kb in the sense or antisense orientation. L6 myoblasts transfected with the GLUT 4 sense cDNA
 .  .L6rG4S transfectants possessed much elevated levels of both endogenous GLUT 4 transcripts 1.4 kb and 2.8 kb .
Transport and immunofluorescence studies showed that this GLUT 4 sense cDNA was responsible for a functional GLUT 4
 .transporter. L6 cells transfected with the GLUT 4 antisense cDNA L6rG4A transfectants possessed only 6% of the L6
level in day 6 cultures. These antisense transfectants were essentially devoid of any functional GLUT 4 transporter. The
activation of transcription of the endogenous GLUT 4 gene in L6rG4S myoblasts suggested auto-regulation of GLUT 4
expression. GLUT 3 expression and activity were not altered in both sense and antisense GLUT 4 transfectants. More
interestingly, GLUT 1 expression was reduced in L6rG4S myoblasts, whereas it was elevated in L6rG4A myoblasts. This
was the first direct evidence indicating GLUT 4 might play an important role in suppressing GLUT 1 expression. q 1998
Elsevier Science B.V. All rights reserved.
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1. Introduction
 .Glucose transporters GLUT are known to play
pivotal roles in energy metabolism. At least six dif-
ferent eukaryotic GLUT isoforms have been identi-
w xfied 1–3 . They possess 12 transmembrane helical
segments with the N- and C-termini and a large
Abbreviations: dGlc, 2-deoxy-D-glucose; GLUT, glucose
transporter; MeGlc, 3-O-methylglucose; PBS, phosphate-buffered
saline
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central loop exposed to the cytoplasm. GLUT trans-
porters have distinct antigenic C-terminal regions,
and are subject to different metabolic and develop-
w xmental regulations 1–3 . They are responsible for the
facilitative uptake of D-glucose and its analogues.
GLUT 1 is most abundant in erythrocytes and brain
microvessels, and is present in most tissues and cell
cultures. GLUT 2 is expressed mainly in pancreatic
b cells, liver, and enterocytes basolateral membranes.
GLUT 3 is found in brain neurons, fetal muscle,
w xskeletal and cardiac myoblasts 4,1–3,5 . GLUT 4 is
present in insulin-sensitive tissues, such as brown and
white adipose tissues, cardiac and skeletal muscles
w x1–3,5,6 . GLUT 5 is actually a fructose transporter
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detected in human enterocyte luminal membranes,
adipocytes, skeletal muscle and sperm. GLUT 7 is
w xlocated in liver microsomes 1–3 .
We have recently demonstrated the presence of the
GLUT 1, 3, and 4 isoforms in rat L6 skeletal myo-
w xblasts 4 . The rat myoblast glucose transport proper-
ties have been examined by transport kinetic analysis,
cytochalasin B binding and photolabelling studies,
w xand by inhibitor studies 7–15 . Transport, and not
phosphorylation, is the rate-limiting step in the up-
 .take of 2-deoxy-D-glucose dGlc , even at very high
w x  .substrate concentrations 7 . A high HAHT and a
 .low LAHT affinity hexose transport processes are
present in undifferentiated glucose-grown myoblasts
w x7 . The transport affinities for HAHT and LAHT are
around 0.6 mM and 3.5 mM, respectively. While
dGlc can be taken up by both processes, 3-O-methyl-
 .glucose MeGlc is taken up primarily by LAHT in
w xglucose-grown myoblasts 14 . These two transport
processes are regulated differently during metabolic
w xand developmental changes 4 . The GLUT 3 and
GLUT 4 transporters are responsible for the HAHT
w xand LAHT processes, respectively 4,13,14 .
Glucose transport activity is affected by changes in
the intrinsic activity, intracellular trafficking, and sta-
w xbility of the GLUT transporters 1–3 . Studies using
myoblast mutants possessing only the GLUT 1 trans-
 .porter mutants M1 and M3 indicate that the appar-
ent K values of this transporter for dGlc andm
MeGlc were around 0.7 mM and 20 mM, respec-
w xtively 14 . More interestingly, this transporter exists
w xin a cryptic form in glucose-grown cells 14 . It can
be activated by glucose starvation, cholera toxin,
protein synthesis inhibitors, energy poisons, and cad-
w xmium 13,14,16–18 . Acute insulin treatment of
adipocytes and myoblasts activates not only glucose
transport activity, but also the translocation of the
GLUT 1, 3 and 4 transporter from intracellular sites
w xto the plasma membrane 19–23 . Insulin has a greater
effect on GLUT 4 translocation than on GLUT 1
w xtranslocation 22–26 . Chronic insulin treatment re-
sults in a greater increase in glucose transport activity
than in the amount of GLUT 1 and GLUT 4 proteins
w xin the plasma membrane 27 . These studies show
that GLUT transport activity can be modulated, di-
rectly or indirectly, by protein–protein interaction,
post-translational modification of the transporter,
w xandror changes in cellular environment 16,28,29 .
A number of mechanisms are involved in regulat-
ing the expression of GLUT transporters. GLUT
expression can be regulated by the transporter itself,
or by other GLUT transporters. Auto-regulation of
the GLUT 3 isoform was recently observed in cells
w xtransfected with the GLUT 3 sense cDNA 30 . An
inverse relationship between GLUT 1 and GLUT 4
expression has been observed in cells undergoing
developmental and physiological changes, or in cells
treated with insulin, cAMP, tumor necrosis factor or
w xmonokines 13,22,31–36 . While chronic insulin
treatment increases GLUT 1 transcript level in L6
muscle cells, 3T3-L1 adipocytes and human fibro-
blasts, it reduces GLUT 4 transcript level in these
w xcells 36–38 . The depletion of GLUT 4 transcript
and protein observed in arachidonic acid treated 3T3-
L1 adipocytes was accompanied by stabilization of
GLUT 1 transcript and increased GLUT 1 transporter
w xlevels 39 . It is not clear whether the observed
inverse relationships are coincidental or causal occur-
rences. There is no direct evidence on whether one or
both transporters are responsible for maintaining this
inverse relationship.
In view of the observation that GLUT 1 expression
was elevated in mutants devoid of the GLUT 4
transporter, it was suggested that GLUT 1 expression
w xwas suppressed by the GLUT 4 transporter 13 . An
innate problem associated with mutant studies is the
inability to distinguish mutation of the GLUT 4
transporter itself from alterations of regulatory com-
ponents. To circumvent this problem, we have trans-
fected rat myoblasts with either the GLUT 4 sense or
antisense cDNAs. This investigation examined the
properties of these GLUT 4 transfectants.
2. Experimental procedures
2.1. Cell cultures
Rat L6 myoblast was originally isolated by Yaffe
w x  .40 . L6rCMV, L6rG4A clones 3, 7 and 11 ,
 .L6rG4S clones 2, 8 and 9 myoblasts are stable
transfectants harbouring the pRcrCMV vector, GLUT
4 antisense cDNA, and GLUT 4 sense cDNA, respec-
tively. Mutant M1 is a GLUT 3yGLUT 4y myoblast
w xoriginally isolated from rat L6 myoblasts 4,13 .
 .  .M1rCMV clones 1 , M1rG4A clones 7 and 11
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 .and M1rG4S clones 8 and 9 are stable transfectants
harbouring the pRcrCMV vector, GLUT 4 antisense
cDNA, and GLUT 4 sense cDNA, respectively. Myo-
blasts were grown in Alpha Minimal Essential
 .Medium Life Technologies , supplemented with 50
 .mgrml of gentamicin sulphate Life Technologies
 .and 10% vrv horse serum Hyclone . Cells were
routinely seeded at a density of 1=106 cells per 150
mm Nunc plates and subcultured every 3 days be-
.fore fusion , cells were detached using 0.4% trypsin
w x4,13 .
2.2. Plasmids and culture media
The pRcrCMV expression vector was purchased
from Invitrogen. Human GLUT 1 and GLUT 3 cD-
NAs were from the Repository of Human and Mouse
DNA Probes and Libraries, ATCC. The GLUT 4
cDNA used was isolated from rat adult skeletal mus-
 .cle clone pSM1-1-2 , and was a generous gift from
w xBirnbaum 41 . The b2-microglobulin cDNA was a
w xgift from Daniel et al. 42 . Qiagen DNA purification
 .kit Qiagen was used to purify plasmid DNAs used
in transfection studies and in generating cDNA
probes.
Bacterial cultures were grown in TB Terrific
.Broth medium containing carbencillin or tetracycline
depending on the resistance markers of the plasmids.
For transformation studies, cells were grown in SOC
 . w xmedium SOB q20 mM glucose 43 .
2.3. Transfection of rat L6 myoblast with GLUT 4
sense or antisense constructs
CMV vectors containing the GLUT 4 insert were
constructed using GLUT 4 cDNAs in the sense or
antisense orientation relative to the CMV promoter.
The rat GLUT 4 cDNA used was a full length GLUT
 . X4 cDNA 2.5 kb including a 5 untranslated region of
105 bp and a 3X untranslated sequence of 800 bp; and
it was inserted into the EcoRI site of the pBluescript
w xKSq vector 41 . In this study, GLUT 4 cDNA was
digested with EcoRI, and then blunt-ended with the
large Klenow fragment of DNA polymerase I at 208C
for 30 min. This was then ligated with the phosphory-
lated HindIII linker using T4 DNA ligase. The
pRcrCMV vector was linearized by digesting with
HindIII and dephosphorylated with calf intestinal al-
kaline phosphatase; this was then ligated to the GLUT
4 cDNA with HindIII-recessed ends using T4 DNA
ligase. Digestion with HindIII and BglII was used to
determine the presence and orientation of the insert,
 .respectively. The GLUT 4 sense clones 2, 8 and 9
 .and antisense clones 3, 7 and 11 constructs were
transfected into L6 or M1 myoblasts using the CaPO4
w xprecipitation method 43 . As a control, the
pRcrCMV vector was also transfected into L6 or M1
myoblasts. Stable transfectants were selected and
cloned by their resistance to geneticin Life Tech-
.nologies . At least five clones of each type of trans-
fectants were isolated.
2.4. Southern blot analysis
Genomic DNA was isolated from L6 transfectants
w xas previously described 44 . Fifteen micrograms of
DNA were digested with HindIII to determine the
incorporation of the GLUT 4 cDNA into the genomic
DNA. Another digestion using Bgl II was carried out
to verify the orientation of GLUT 4 inserts in the
transfectants. The digests were run on a 0.8% agarose
gel and transferred to an ICN Biotrans nylon mem-
brane. The sizes of the DNA fragments were deter-
 .mined using the 1 kb DNA ladder GibcoBRL . The
blot was then washed in 2= SSC for 10 min and
air-dried for 30 min. After pre-hybridization for 1 h
at 428C, the blot was hybridized with 32Py labelled
GLUT 4 cDNA overnight at 378C. The resulting blot
was exposed to Kodak X-OMAT AR film.
2.5. Northern blot analysis
 .qPoly A RNA was extracted from myoblasts
using the Invitrogen Fast Tracke kit. Northern blot
studies were carried out as previously described
w x4,13 , using 1 mg mRNA per lane. The sizes of the
transcripts were determined through the use of the
 .0.24–9.5 RNA ladder GibcoBRL . The blot was
initially probed with labelled b2-microglobulin
cDNA to determine sample loading. It was then
probed with GLUT 1, GLUT 3 and GLUT 4 cDNAs.
The blot was stripped with 60% formamide at 658C
for 2 h before hybridizing with a new probe. After
exposure to Kodak X-OMAT AR film, the autoradio-
gram was analysed using the JAVA Video Analysis
 .Software Jandel Scientific . Measurements were
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made in the linear range of the optical density. Two
 .qpoly A RNA preparations were made from each
cell type, samples from each preparation were probed
at least three times. The amount of mRNA present in
each lane was normalized according to the amount of
b2-microglobulin mRNA present in each sample. In
calculating the relative transcript levels, the amount
in day 2 L6 culture was used as 100%.
2.6. Immunofluorescence studies
Immunofluorescence studies were conducted using
rabbit anti-rat GLUT 4 antibodies East Acres Bio-
. w xlogicals, Southbridge, MA 45,46 . The secondary
antibody was rhodamine-labelled TRITC-conjugated
 . Affini Pure goat anti-rabbit IgG HqL Jackson
.Immunoresearch Lab. . Rabbit IgG was used as a
control. Myoblasts were grown at low density on
acid-washed sterile coverslips in Falcon six-well
 .plates 35=15 mm for two days in Alpha medium.
After washing twice with ice cold phosphate-buffered
saline PBS: 137 mM NaCl, 2.7 mM KCl, 8.1 mM
Na HPO , 1.5 mM KH PO , 0.9 mM CaCl , and2 4 2 4 2
.0.5 mM MgCl , cells were fixed with Carnoy’s Fix2
 .30% methanol and 10% glacial acetic acid for 2
min followed by 100% methanol for 10 min. After
washing twice with PBS, cells were permeabilized
using 0.1% Triton X-100 in PBS for 5 min, and then
blocked with 1% BSA in PBS for 30 min. They were
then washed three times with PBS at room tempera-
ture. Each coverslip was then incubated for 1 h with
100 ml of primary antibody diluted 1:30 in cPBS
containing 0.2% gelatin, and 0.05% Tween 20. This
was followed by two 5-min wash with PBS. Each
coverslip was then incubated with 100 ml of rho-
damine-labelled secondary antibody for 1 h at room
temperature. After washing twice with PBS, the cov-
erslips were examined under a fluorescence micro-
scope. Pictures of representative cells were taken
using Kodak Tri-X film. All pictures were taken at
the same exposure time, and were printed under the
same conditions to allow comparison.
2.7. Whole cell transport studies
Transport studies were carried out using six-well
w xFalcon plates 47,48 . Cells were routinely plated at a
density of 1.5=105 cellsrwell. Medium was aspi-
rated and each well was washed with 10 ml of PBS.
Nine hundred microlitres of uptake buffer PBS con-
.taining 1 mgrml bovine serum albumin were added
to each well. Transport studies were carried out at
238C and were initiated by adding 100 ml of radioac-
tive substrate to the desired final concentration. At
appropriate times, uptake was terminated by rapidly
 .washing the cells twice less than 15 s with 10 ml of
ice-cold PBS. In the case of MeGlc uptake, cells
were washed with cold PBS containing 1 mM mer-
curic chloride. Samples were taken at 15, 30, 45 and
60 s after the addition of radioactive substrate. Cells
were solubilized with 1 ml of 0.1% Triton X-100,
and 0.8 ml aliquots were counted in 10 ml of scintil-
lation fluid. Under these conditions, the uptake of
MeGlc and dGlc was linear with time, and over 95%
w xof the internalized dGlc were phosphorylated 7 .
Cells in two wells from each plate were detached
with 0.1% trypsin, and counted using a Coulter
counter. Studies were carried out in duplicate and
each experiment was repeated at least twice. Results
were consistent in all cases. Data were analysed by a
linear least squares regression fit program SlideWrite
Pluse, version 4.0, Advanced Graphics Software,
.Sunnyvale, CA , and by a non-linear regression data
analysis program Enzfitter program, Biosoft, Cam-
.bridge, UK .
2.8. Materials
w 32 x w 3 xa- P -dCTP, 2-deoxy-D- 1,2- H glucose and 3-
w 3 xO- methyl- H methyl-D-glucose were purchased from
ICN Biochemicals. Reagents used in bacterial cul-
tures were from Difco. Restriction and modifying
enzymes were purchased from Pharmacia, whereas l
DNA HindIII digest and l DNA BstEII digest were
from New England Labs. All other chemicals were
purchased from commercial sources and were of the
highest available purity.
3. Results
3.1. Transfection of rat L6 myoblast with GLUT 4
sense or antisense cDNA
To examine the regulatory roles of the GLUT 4
transporter, rat L6 myoblasts were transfected with
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GLUT 4 cDNAs in the sense or antisense orientation.
The presence of the GLUT 4 cDNA insert was
determined using genomic DNAs from day 2 cultures
 .of L6, L6rCMV, L6rG4S clones 2, 8 and 9 and
 .L6rG4A clones 3, 7 and 11 myoblasts. After diges-
tion with HindIII, these genomic DNAs were probed
with 32Py labelled GLUT 4 cDNA. The exogenous
2.5 kb GLUT 4 cDNA was detected as a very intense
and broad band in L6rG4S and L6rG4A myoblasts,
 .but not in L6 and L6rCMV myoblasts Fig. 1A . The
fairly faint 3.1 kb band detected in all cell lines was
likely the endogenous GLUT 4 gene. Orientation of
Fig. 1. Southern blot analyses of rat L6 myoblasts transfected with GLUT 4 sense or antisense cDNAs. Genomic DNAs were isolated
 .  .from L6 myoblasts, control transfectant L6rCMV , GLUT 4 antisense transfectant L6rG4A , and GLUT 4 sense transfectant
 .L6rG4S . Southern blot analyses were carried out as described in the text. Panel A indicates digestion of 10 mg of genomic DNA with
HindIII. This demonstrates the presence of the 2.5 kb GLUT 4 cDNA insert in L6rG4A and L6rG4S myoblasts. Panel B indicates
digestion of 10 mg of genomic DNA with BglII. This indicates the orientation of the GLUT 4 cDNA insert. Lanes 1, 2, 3, and 4 in
Panels A and B denote genomic DNAs from L6, L6rCMV, L6rG4S and L6rG4A myoblasts, respectively. Lane 5 in Panel B indicates
the presence of the 5.7 kb and 1.8 kb fragments when a 0.8% agarose gel was overloaded with a BglII digested genomic DNA from
L6rG4A myoblast, and run for a longer time to achieve better separation. The numbers beside each panel indicate DNA fragment sizes in
kb. Panel C is the linear orientation CMVrGLUT 4 BglII restriction map. The thick line denotes the GLUT 4 cDNA, and the thin line
represents the pRcrCMV vector.
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the GLUT 4 cDNA insert was determined using
 .genomic DNAs digested with Bgl II Fig. 1B . As
expected from the CMVrGLUT 4 restriction map
 .Fig. 1C , the GLUT 4 cDNA probe was able to
recognize a 2.4-kb and a 5.1-kb band in L6rG4S
 .myoblasts Fig. 1B, lane 3 , and a 1.8-kb and 5.7-kb
 .band in L6rG4A myoblasts Fig. 1B, lanes 4 and 5 ,
and it could hardly label any DNA bands in L6 lane
.  .  .1 and L6rCMV lane 2 myoblasts Fig. 1B . Thus,
the GLUT 4 cDNA inserts were present in the ex-
pected orientations in L6rG4S and L6rG4A myo-
blasts. The GLUT 3yGLUT 4y mutant, M1, was
also transfected with pRcrCMV vector, the GLUT 4
sense and antisense cDNAs. The presence and orien-
tation of these exogenous cDNAs in various M1
transfectants were confirmed using similar ap-
 .proaches data not shown .
3.2. GLUT 4 transcript le˝els in L6 transfectants
Northern blot studies were carried out using poly
 .qA RNAs from days 2, 4 and 6 cultures of L6
w xtransfectants. Similar to previous observations 4,27 ,
a 1.4-kb and a 2.8-kb transcript were recognized by
the GLUT 4 cDNA probe in all cell types examined
 .Figs. 2 and 3 . These two GLUT 4 transcripts were
thought to arise from differential RNA processing
w x4,27 . L6 and L6rCMV myoblasts possessed similar
levels of the 1.4-kb and 2.8-kb GLUT 4 transcripts;
about a threefold increase was observed between day
 .2 and day 6 cultures Fig. 3 . More interestingly,
L6rG4S transfectants possessed relatively constant
levels of the endogenous 1.4-kb and 2.8-kb GLUT 4
transcripts, and they were maintained at about three
times higher than those in day 2 L6 myoblasts Fig.
.3 . It was important to note that a transcript corre-
sponding to the size of the exogenous GLUT 4
 .cDNA 2.5 kb was hardly detectable in these trans-
 .fectants Fig. 2, lane 3 . This showed that transcrip-
tion of the endogenous GLUT 4 gene was activated,
directly or indirectly, by the exogenous GLUT 4
sense cDNA; this suggested auto-regulation of GLUT
4 expression. Similar auto-regulation of the GLUT 3
transporter was also observed in rat myoblast trans-
w xfectants harbouring the GLUT 3 sense cDNA 30 .
In the case of L6rG4A myoblasts, about 15% and
12% of the L6 1.4-kb and 2.8-kb GLUT 4 transcripts
Fig. 2. Autoradiogram showing the levels and sizes of the GLUT
 .q4 transcripts. Poly A RNAs were isolated from day 2 culture
of different clones of L6, L6rCMV, L6rG4A and L6rG4S
myoblasts. Two preparations were made from each cell type and
samples from each preparation were probed at least three times.
Northern blot analyses were carried out as described in the text.
 .The 0.24–9.5 kb RNA ladder GibcoBRL was used to determine
transcript sizes. Panel A is an autoradiogram indicating the levels
and sizes of the transcripts labelled by the GLUT 4 cDNA. The
number beside the panel indicates sizes of transcripts and stan-
dards in kb. Panel B shows the Northern blot probed with the
b2-microglobulin cDNA. Lanes 1, 2, 3 and 4 denote L6,
L6rCMV, L6rG4S, and L6rG4A myoblasts, respectively. It is
important to note that a transcript corresponding to the size of the
exogenous 2.5 kb GLUT 4 cDNA could not be detected in both
L6rG4A and L6rG4S transfectants.
 .were detected in day 2 culture, respectively Fig. 3 .
These transcripts remained at relatively low levels
during growth. Day 6 culture of L6rG4A myoblasts
possessed only 8% and 4% of the 1.4-kb and 2.8-kb
GLUT 4 transcripts present in day 6 L6 cultures,
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Fig. 3. GLUT 4 transcript levels in GLUT 4 transfectants. Poly
 .qA RNAs were isolated from day 2 to day 6 cultures of
different clones of L6, L6rCMV, L6rG4A and L6rG4S myo-
blasts. Northern blot analyses were carried out as described in the
text. Two preparations were made from each cell type and
samples from each preparation were probed at least three times.
GLUT 4 transcript levels in each culture were normalized accord-
ing to the amount of b2-microglobulin mRNA present in each
preparation. Transcript levels of day 2 L6 culture were taken as
100%. ‘, I, % and ’ denote L6 and L6rCMV, L6rG4A and
L6rG4S myoblasts, respectively. Panels A and B indicate the
 .  .GLUT 4 2.8 kb and GLUT 4 1.4 kb transcript levels, respec-
tively.
 .respectively Fig. 3 . Thus, expression of the endoge-
nous GLUT 4 gene was suppressed in cells harbour-
ing the GLUT 4 antisense cDNA.
3.3. GLUT 4 transport acti˝ities of L6 transfectants
 .Although 3-O-methyl D-glucose MeGlc has been
shown to be taken up by both GLUT 1 and GLUT 4
w xtransporters 14 , it is taken up primarily by the
GLUT 4 transporter in glucose-grown myoblasts, as
the GLUT 1 transporter is not functional in glucose-
w xgrown cells 14 . This sugar analogue was therefore
used to examine the GLUT 4 transport properties of
various transfectants. Analysis of transport data by
the Lineweaver–Burk plot indicated that both
L6rCMV and L6rG4S transfectants had similar
 .GLUT 4 transport kinetic properties Fig. 4 . Analy-
 .Fig. 4. Kinetics of 3-O-methylglucose MeGlc uptake by L6
transfectants. L6 transfectants were grown in Alpha medium
containing 25 mM D-glucose. Transport studies were carried out
as described in the text. Studies were carried out in duplicate and
each experiment was repeated at least twice. Initial rates of
uptake were calculated from the amount of MeGlc taken up at
 .238C in 15, 30, 45 and 60 s. Velocity V is expressed as nmoles
of MeGlc taken up per min per 1=105 cells. S refers to the
 .concentration of MeGlc in mmoles per litre used. An equal
amount of radioactivity was added to each MeGlc concentration.
Data were analysed by the Lineweaver–Burk plot. The lines
through the symbols were drawn by a linear least squares regres-
 .sion fit program SlideWrite Pluse . I, ’, % denote MeGlc
uptake by L6rCMV, L6rG4S and L6rG4A myoblasts, respec-
tively.
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sis of data by a linear regression program indicated
that intercepts on the X-axis were y0.2057, and
y0.24748 for L6rCMV, and L6rG4S cells, respec-
tively. Thus, the apparent K values of MeGlcm
uptake by L6rCMV and L6rG4S were 4.86 mM and
4.04 mM, respectively.
Fig. 5. Immunofluorescence studies using anti-GLUT 4 antibodies. Immunofluorescence studies were carried out as described in the text.
 .These studies were carried out using rabbit anti-rat GLUT 4 antibodies East Acres Biologicals . Rhodamine-labelled TRITC-conjugated
 .AffiPure goat anti-rabbit IgG Jackson Immunoresearch Lab. was used as the secondary antibody. Panels a, b, and c denote L6rCMV,
L6rG4S, and L6rG4A transfectants, respectively; whereas, panels d, e, and f denote M1rCMV, M1rG4S, and M1rG4A transfectants,
respectively.
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Analysis of data by a non-linear regression fit to
the Michaelis–Menten hyperbola revealed that the
apparent K values of MeGlc transport by L6rCMVm
and L6rG4S cells were 4.68"1.09 mM and 4.13"
0.09 mM, respectively. These were similar to those
 .obtained by the Lineweaver–Burk analysis Fig. 4 .
As shown in Fig. 4, L6rG4S transfectants exhib-
ited increases in the rates of MeGlc uptake when
compared with those of L6rCMV transfectants. This
was probably due to an increase in the number of
GLUT 4 transporters. The intracellular volume of rat
L6 myoblasts was previously determined to be around
5 w x0.22 ml per 10 cells 7,14 . When the external
MeGlc concentrations were 0.125 mM, 0.2 mM and
0.3 mM, the intracellular MeGlc concentrations in
L6rCMV myoblasts were calculated to be around
0.106 mM, 0.17 mM, and 0.28 mM, respectively;
whereas those in L6rG4S myoblasts were 0.136
 .mM, 0.21 mM, and 0.316 mM, respectively Fig. 4 .
This showed that equilibration of MeGlc was readily
achieved in L6rCMV and L6rG4S myoblasts. The
MeGlc transport capacities of these two cell lines
were around 900 pmolrminr105 cells.
Unlike L6rCMV and L6rG3S transfectants,
L6rG4A transfectants were unable to take up MeGlc
via an efficient transport process. In Fig. 4, the line
denoting the L6rG4A transport kinetic properties
was drawn by a linear least squares regression fit
 .program SlideWrite Pluse . The intercept of this
line on the X-axis was calculated by a linear regres-
sion program to be at q0.00484. Since this line
extrapolated close to zero, it might be surmised that
MeGlc entered the cells via an extremely low affinity
transport process, or simple diffusion. Similar conclu-
sions were also made when data were analysed by a
non-linear regression fit to the Michaelis–Menten
 .hyperbola Enzfitter program, Biosoft . This lack of a
functional GLUT 4 transporter was expected as these
cells contained very low GLUT 4 transcript level
 .Fig. 3 . Unlike L6rCMV and L6rG4S myoblasts,
only residual amount of the GLUT 4 transporter was
detected in L6rG4A myoblasts by immunofluo-
 .rescence studies Fig. 5 .
3.4. GLUT 4 transport acti˝ities in M1 transfectants
Mutant M1 is a GLUT 3yGLUT 4y mutant with a
w xsimilar genetic background as rat L6 myoblast 4,13 .
Even though its GLUT 1 level was three times higher
than that in L6 myoblast, glucose-grown M1 myo-
blast was devoid of any carrier-mediated glucose
w xtransport processes 13,14 . Despite this deficiency,
this glucose-grown mutant could still take up a sub-
w xstantial amount of glucose via simple diffusion 14 .
When grown in the presence of 25 mM D-glucose,
the doubling times of M1 and L6 myoblasts were 25
w xand 22 h, respectively 14 . The absence of any
functional GLUT transporters in glucose-grown M1
myoblasts makes this mutant an ideal tool to examine
the functional states of the protein encoded by the
GLUT 4 sense cDNA.
M1 myoblasts were first transfected with the GLUT
4 sense or antisense cDNA. Immunofluorescence
studies showed that the GLUT 4 transporter was
detected in M1 transfectants harbouring the GLUT 4
 .  .sense cDNA M1rG4S Fig. 5e , but not in transfec-
tants harbouring the pRcrCMV expression vector
 .  .M1rCMV Fig. 5d or the GLUT 4 antisense cDNA
 .  .M1rG4A Fig. 5f . Thus, the protein encoded by
 .Fig. 6. Kinetics of 2-deoxy-D-glucose dGlc uptake by M1
transfectants. M1 transfectants were grown in Alpha medium
containing 25 mM D-glucose. Transport studies were carried out
as described in Fig. 4, except that dGlc was used as the transport
substrate. Studies were carried out in duplicate and each experi-
 .ment was repeated at least twice. Velocity V is expressed as
nmoles of dGlc taken up per min per 1=105 cells. S refers to the
 .concentration of dGlc in mmoles per litre used. An equal
amount of radioactivity was added to each dGlc concentration.
Data were analysed by the Lineweaver–Burk plot. The lines
through the symbols were drawn by a linear least squares regres-
 .sion fit program SlideWrite Pluse . I, ’, % denote dGlc
uptake by M1rCMV, M1rG4S and M1rG4A transfectants,
respectively.
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Fig. 7. GLUT 3 transcript levels in L6 transfectants. Northern
blot analysis and quantification of transcript levels were per-
formed as described in Fig. 3. Two preparations were made from
each cell type and samples from each preparation were probed at
least three times. GLUT 3 transcript level was determined by
probing with the GLUT 3 cDNA. Transcript levels in each
culture were normalized according to the amount of b2-micro-
globulin transcript present in each preparation. Transcript levels
of day 2 L6 culture were taken as 100%. ‘, I, % and ’
denote L6 and L6rCMV, L6rG4A and L6rG4S myoblasts,
respectively.
the GLUT 4 sense cDNA was recognized by the
rabbit anti-GLUT 4 antibody.
To examine the functional states of GLUT 1 and 4
transporters in M1 transfectants, transport kinetic
studies were carried out using 2-deoxy-D-glucose
 .dGlc , which is taken up by the GLUT 1, 3 and 4
transporters. The apparent transport affinities of
GLUT 1, 3 and 4 for dGlc are around 0.7 mM, 0.6
w xmM, and 3.5 mM, respectively 13,14 . As shown in
Fig. 6, dGlc was taken up by glucose-grown
M1rCMV and M1rG4A myoblasts via a very ineffi-
cient transport process, thus confirming the absence
of any functional GLUT transporters. On the other
hand, dGlc was taken up by M1rG4S myoblasts with
 .an affinity of around 1.7 mM Fig. 6 . This indicated
that the protein encoded by the GLUT 4 sense cDNA
was able to function as a GLUT transporter. The
transport capacity of M1rG4S myoblasts for dGlc
was around 576 pmolrminr105 cells.
3.5. GLUT 3 transcript le˝el and transport acti˝ity in
L6 transfectants
Previous studies using glucose transport mutants
did not allow one to examine the effect of GLUT 4
on GLUT 3 expression, as it was not possible to
isolate mutants defective only in the GLUT 4 isoform
w x13,14 . The availability of transfectants over- or
under-expressing GLUT 4 provided an excellent op-
portunity to examine the effect of GLUT 4 on GLUT
3 expression and activity.
 .Similar levels of the GLUT 3 transcript 4.1 kb
were present in L6, L6rCMV, L6rG4A and L6rG4S
 .transfectants Fig. 7 . The levels of these transcripts
declined upon prolonged growth. Since L6rG4A and
L6rG4S myoblasts were impaired in myogenic dif-
ferentiation, whereas L6 and L6rCMV myoblasts
 .were not unpublished observation , the observed de-
cline in GLUT 3 transcript was not likely due to
Fig. 8. Kinetics of 2-deoxy-D-glucose uptake by L6 transfectants.
L6 transfectants were grown in Alpha medium containing 25 mM
D-glucose. Transport studies were carried out as described in Fig.
4, except that dGlc was used as the transport substrate. Studies
were carried out in duplicate and each experiment was repeated
 .at least twice. Velocity V is expressed as nmoles of dGlc taken
up per min per 1=105 cells. S refers to the concentration of dGlc
 .in mmoles per litre used. An equal amount of radioactivity was
added to each dGlc concentration. Data were analysed by the
Lineweaver–Burk plot. The lines through the symbols were
drawn by a linear least squares regression fit program SlideWrite
.Pluse . I, ’, % denote dGlc uptake by L6rCMV, L6rG4S
and L6rG4A transfectants, respectively.
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myogenic differentiation. This decline was probably
brought about by increases in cell density during
w xgrowth 4 .
Even though dGlc is taken up by GLUT 1 and
GLUT 3 transporters with similar transport affinities,
the GLUT 3 transport property can be examined by
using glucose-grown cells, in which the GLUT 1
w xtransporter is not functional 13,14 . Transport kinetic
analysis revealed that all three types of glucose-grown
L6 transfectants took up dGlc with a similar transport
 .affinity Fig. 8 . Analysis of data by a non-linear
regression fit to the Michaelis–Menten hyperbola
indicated that the apparent K values of dGlc uptakem
by L6rCMV, L6rG4S and L6rG4A myoblasts were
0.64"0.07 mM, 0.51"0.06 mM and 0.45"0.09
mM, respectively. Thus changes in GLUT 4 levels
had no effect on the GLUT 3 transcript level and its
transport affinity.
Fig. 9. GLUT 1 transcript levels in L6 transfectants. Northern blot
analysis and quantification of transcript levels were performed as
described in Fig. 3. Two preparations were made from each cell
type and samples from each preparation were probed at least
three times. GLUT 1 transcript level was determined by probing
with the GLUT 1 cDNA. Transcript levels in each culture were
normalized according to the amount of b2-microglobulin tran-
script present in each preparation. Transcript levels of day 2 L6
culture were taken as 100%. ‘, I, % and ’ denote L6 and
L6rCMV, L6rG4A and L6rG4S myoblasts, respectively.
3.6. GLUT 1 transcript and transport acti˝ity in L6
transfectants
The effects of over- or under-expression of the
GLUT 4 isoform on GLUT 1 expression were also
examined. GLUT 1 transcript levels in days 2, 4 and
6 cultures of L6rG4A transfectants were about 147%,
146% and 150% of the corresponding L6 and
 .L6rCMV levels, respectively Fig. 9 . This showed
that increases in GLUT 1 expression were observed at
all stages of growth. Conversely, GLUT 1 transcript
levels were reduced in transfectants harbouring much
elevated level of the GLUT 4 isoform. GLUT 1
transcript levels in days 2, 4 and 6 L6rG4S cultures
were about 69%, 56% and 20% of the corresponding
values in L6 and L6rCMV cells, respectively Fig.
.9 . This study showed that the GLUT 1 transcript
levels in L6rG4S myoblasts were distinctly lower
than those in L6rG4A myoblasts at all stages of
growth. Increases in GLUT 1 transcript and trans-
porter levels were also observed in mutants deficient
w xin the GLUT 4 transporter 4,13 . Our present trans-
fection studies show that the GLUT 4 isoform may
play a key role in maintaining the inverse relationship
between GLUT 4 and GLUT 1 expression.
4. Discussion
Considerable efforts have been focused on the
 .mechanisms by which glucose transport GLUT pro-
cesses can be regulated in eukaryotic cells. Studies on
the effects of insulin, tumor necrosis factor, glucose
starvation, exercise and development on the expres-
sion, intracellular location, and activities of the GLUT
1 and GLUT 4 transporters have yielded valuable
information on the molecular mechanisms and the
signal transduction pathways by which glucose trans-
w xport processes can be regulated 1–3,31–35,49 . Not
much is presently known on how the expression and
activity of one GLUT isoform can be affected by
itself, or by other GLUT isoforms.
Studies using mutants deficient in the GLUT 4
isoform have generated valuable information on the
w xeffects of under-expression of this transporter 13 .
However, these studies were unable to ascertain
whether the observed changes were due to mutations
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in the transporter itself, or in some regulatory compo-
nents. One approach to tackle this problem is to
transfect cells with the GLUT 4 sense or antisense
cDNAs. This will enable one to examine the effects
of over- and under-expression of the GLUT 4 iso-
form on its own expression, and on the expression of
the GLUT 1 andror GLUT 3 isoforms under identi-
cal conditions.
L6 transfectants harbouring the GLUT 4 sense
 .cDNA L6rG4S possessed much elevated levels of
both endogenous 1.4 kb and 2.8 kb GLUT 4 tran-
scripts at all stages of growth; the levels of these
transcripts were about three times higher than those
 .in day 2 L6 myoblasts Fig. 3 . Conversely, L6
transfectants harbouring the GLUT 4 antisense cDNA
 .L6rG4A possessed much reduced level of the en-
dogenous GLUT 4 transcripts; L6rG4A myoblasts
had around 6% of the L6 level in day 6 cultures Fig.
.3 . The observed activation of transcription of the
endogenous GLUT 4 gene by the GLUT 4 sense
cDNA therefore suggests auto-regulation of the GLUT
4 gene. This was similar to the auto-regulation of the
GLUT 3 isoform observed in cells transfected with
w xan exogenous GLUT 3 sense cDNA 30 .
 .Not much is known on the mechanism s that
bring about auto-regulation. We have shown in this
study that the GLUT 4 sense cDNA codes for a
 .functional GLUT 4 transporter Figs. 5 and 6 . It is
possible that the GLUT 4 transporter may modulate
 .the level of functional transcription factor s required
for regulating GLUT 4 expression. This may be
brought by interaction of the GLUT 4 transporter
with specific cytoplasmic proteins. We have recently
observed that the central cytoplasmic loop of the
GLUT 4 transporter can interact directly with several
cytoplasmic proteins. Attempts are being made to
determine the involvement of these components in
regulating GLUT 4 expression.
The availability of L6rG4S and L6rG4A trans-
fectants provides a unique opportunity to examine the
effect of GLUT 4 on GLUT 3 expression. Despite
differences in their GLUT 4 transcript levels, both
types of transfectants possessed similar amount of the
 .GLUT 3 transcript Fig. 7 . Transport kinetic analy-
ses revealed that the apparent K values of dGlcm
uptake by glucose-grown L6rCMV, L6rG4S and
L6rG4A were 0.64"0.07 mM, 0.51"0.06 mM
and 0.45"0.09 mM, respectively. This showed that
changes in GLUT 4 level had no effect on the
expression and kinetic properties of the GLUT 3
transporter.
While there are ample indirect evidence on the
inverse relationship between GLUT 1 and GLUT 4
w xexpression 13,14,22,31–36 , it is not clear whether
these are coincidental or causal occurrences. The
following observations indicate that the GLUT 4
transporter may play a crucial role in suppressing
 .GLUT 1 expression. i Increases in GLUT 4 expres-
sion occurred before the major decline of the GLUT
w x1 transcript during myogenic differentiation 13 .
Similar temporal order of expression was also ob-
w xserved in adipose tissues 38 . Thus GLUT 4 expres-
sion was altered before any observed changes in
 .GLUT 1 expression. ii Both cytochalasin B binding
and immunoblotting studies using plasma membrane
and microsomal preparations revealed that mutants
deficient in the GLUT 4 transporter possessed 2–3
times the amount of GLUT 1 transporter present in
w xtheir parental L6 myoblasts 4,13 . Similarly, the
GLUT 1 transcript levels in GLUT 4y mutants were
w xabout twice that present in L6 myoblasts 4,13 .
These studies clearly indicated that both GLUT 1
transporter and expression were increased in the ab-
 .sence of the GLUT 4 isoform. iii Even though
GLUT 1 transcript level was doubled in glucose-
starved L6 myoblasts, their GLUT 4 transcript level
w xremained unaltered 13 ; thus, the GLUT 1 isoform
was not likely to play a role in modulating GLUT 4
expression.
The availability of GLUT 4 transfectants allowed
one to examine directly the relationship between
these two GLUT isoforms. We have shown in this
study that the L6rG4S myoblasts harboured substan-
tial amount of the GLUT 4 cDNA in the correct
 .orientation Fig. 1 , and their GLUT 4 transcripts
were maintained at a level about three times higher
 .than those in day 2 L6 myoblasts Fig. 3 . Both
immunofluorescence and transport studies showed
that the protein encoded by the GLUT 4 sense cDNA
was not only recognized by the rabbit anti-GLUT 4
 .antibody Fig. 5b , but also able to function as a
 .transporter Fig. 6 . More importantly, overexpres-
sion of GLUT 4 in L6rG4S myoblasts was accompa-
 .nied by a reduction of GLUT 1 expression Fig. 9 .
Conversely, L6rG4A transfectants were found to
possess about 13% of the L6 GLUT 4 transcript
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 . levels Fig. 3 ; hardly any GLUT 4 transporter Fig.
.  .5c and GLUT 4 transport activity Fig. 6 could be
detected in these transfectants. More importantly,
these transfectants possessed much elevated levels of
 .the GLUT 1 transcript at all stages of growth Fig. 9 .
This is the first direct evidence indicating the role of
the GLUT 4 transporter in modulating GLUT 1 ex-
pression. We are currently studying the mechanisms
involved.
In summary, studies using transfectants harbouring
the GLUT 4 sense or antisense cDNAs revealed that
the GLUT 4 transporter might play important roles in
regulating its own expression and the expression of
the GLUT 1 transporter. The GLUT 4 transporter
may interact with appropriate signal transducers; this
interaction will in turn regulate the level of functional
transcription factors. While some of these transcrip-
tion factors may function by suppressing GLUT 1
expression, others which may or may not be the
.same transcription factors may serve by activating
GLUT 4 transcription.
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